Diagnostic criteria for late-onset (childhood and adult) Pompe disease

Muscle and Nerve

Volumn 40, Issue 1, 2009, Pages 149-160

  Al Lozi, Muhammad T ^a   Amato, Anthony A ^b   Barohn, Richard J ^c   Cupler, Edward J ^d   Kishnani, Priya S ^e   Leshner, Robert T ^f   Mozaffar, Tahseen ^g   Kishnani, Priya Sunil ^h  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^e DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Acid glucosidase; Acid maltase deficiency; Lysosomal storage disorder; Neuromuscular disease; Pompe disease

Indexed keywords

ALPHA GLUCOSIDASE;

ADULT DISEASE; ALGORITHM; ARTICLE; CHILDHOOD DISEASE; CONSENSUS DEVELOPMENT; DIAPHRAGM; DYSPNEA; ENZYME ACTIVITY; GENE SEQUENCE; GLYCOGEN STORAGE DISEASE TYPE 2; HUMAN; LUNG FUNCTION; MOTOR PERFORMANCE; MUSCLE STRENGTH; MUSCLE WEAKNESS; PRIORITY JOURNAL; RARE DISEASE;

AGE OF ONSET; ALGORITHMS; ALPHA-GLUCOSIDASES; CONSENSUS; DIAPHRAGM; ELECTROMYOGRAPHY; GLYCOGEN STORAGE DISEASE TYPE II; HUMANS; MUSCLE WEAKNESS; MUSCULAR DYSTROPHIES, LIMB-GIRDLE; NEURAL CONDUCTION; PHYSICAL EXAMINATION; PUBMED;

EID: 67650240388     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.21393     Document Type: Article

References (62)

1. Hirschhorn R, Reuser AJJ. Glycogen storage disease type II: acid α-glucosidase (acid maltase) deficiency. In: Valle D, Beaudet AL, Vogelstein B, Kinzler KW, Antonarakis SE, Ballabio A, editors. The online metabolic and molecular bases of inherited disease, chap. 135. Scriver's OMMBID Website. http://www.ommbid.com/. Accessed January 23, 2008.
2. Koeberl DD, Kishnani PS, Chen YT. Glycogen storage disease types I and II: treatment updates. J Inherit Metab Dis 2007;30:159-164. (Pubitemid 46487996)
3. Raben N, Plotz P, Byrne BJ. Acid a-glucosidase deficiency (glycogenosis type II, Pompe disease). Curr Mol Med 2002;2:145-166. (Pubitemid 34649837)
4. Kishnani PS, Howell RR. Pompe disease in infants and children. J Pediatr 2004;144:S35-S43.
5. Kishnani PS, Steiner RD, Bali D, Berger K, Byrne BJ, Case LE, et al. Pompe disease diagnosis and management guideline. Genet Med 2006;8:267-288. (Pubitemid 44297314)
6. Kishnani PS, Hwu WL, Mandel H, Nicolino M, Yong F, Corzo D. A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease. J Pediatr 2006;148:671-676. (Pubitemid 43776899)
7. van den Hout HM, Hop W, van Diggelen OP, Smeitink JA, Smit GP, Poll-The BT, et al. The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature. Pediatrics 2003;112:332-340. (Pubitemid 36951395)
8. Winkel LPF, Hagemans MLC, van Doorn PA, Loonen MC, Hop WJ, Reuser AJ, et al. The natural course of non-classic Pompe's disease; a review of 225 published cases. J Neurol 2005;252:875-884. (Pubitemid 41186956)
9. Chien YH, Chiang SC, Zhang XK, Keutzer J, Lee NC, Huang AC, et al. Early detection of Pompe disease by newborn screening is feasible: results from the Taiwan Screening Program. Pediatrics 2008;122:e39-45.
10. Ausems MGEM, Verbiest J, Hermans MMP, Kroos MA, Beemer FA, Wokke JH, et al. Frequency of glycogen storage disease type II in the Netherlands: implications for diagnosis and genetic counselling. Eur J Hum Genet 1999;7:713-716. (Pubitemid 29424063)
11. Ausems MGEM, Lochman P, van Diggelen OP, Ploos van Amstel HK, Reuser AJJ, Wokke JHJ. A diagnostic protocol for adult-onset glycogen storage disease type II. Neurology 1999;52:851-853. (Pubitemid 29120196)
12. Martiniuk F, Chen A, Mack A, Arvanitopoulos E, Chen Y, Rom WN, et al. Carrier frequency for glycogen storage disease type II in New York and estimates of affected individuals born with the disease. Am J Med Genet 1998;79:69-72. (Pubitemid 28402423)
13. Flachenecker P. Epidemiology of neuroimmunological diseases. J Neurol 2006;253(Suppl 5):V2-V8.
14. Raben N, Roberts A, Plotz PH. Role of autophagy in the pathogenesis of Pompe disease. Acta Myol 2007;26:45-48. (Pubitemid 47400724)
15. Reuser AJ, Drost MR. Lysosomal dysfunction, cellular pathology and clinical symptoms: basic principles. Acta Paediatr Suppl 2006;95:77-82. (Pubitemid 43739101)
16. Fukuda T, Ewan L, Bauer M, Mattaliano RJ, Zaal K, Ralston E, et al. Dysfunction of endocytic and autophagic pathways in a lysosomal storage disease. Ann Neurol 2006;59:700-708.
17. Raben N, Takikita S, Pittis MG, Bembi B, Marie SK, Roberts A, et al. Deconstructing Pompe disease by analyzing single muscle fibers: to see a world in a grain of sand. Autophagy 2007;3:546-552. (Pubitemid 350060050)
18. Hagemans MLC, Winkel LPF, Van Doorn PA, Hop WJ, Loonen MC, Reuser AJ, et al. Clinical manifestation and natural course of late-onset Pompe's disease in 54 Dutch patients. Brain 2005;128(Pt 3):671-677. (Pubitemid 40380201)
19. Müller-Felber W, Horvath R, Gempel K, Podskarbi T, Shin Y, Pongratz D, et al. Late onset Pompe disease: clinical and neurophysiological spectrum of 38 patients including long-term follow-up in 18 patients. Neuromuscul Disord 2007;17:698-706. (Pubitemid 47362681)
20. Winchester B, Bali D, Bodamer OA, Caillaud C, Christensen E, Cooper A, et al. Methods for a prompt and reliable laboratory diagnosis of Pompe disease: report from an international consensus meeting. Mol Genet Metab 2008;93:275-281.
21. Bembi B, Cerini E, Danesino C, Donati MA, Gasperini S, Morandi L, et al. Diagnosis of glycogenosis type II. Neurology 2008;71:S4-11.
22. Murphy MK, Black NA, Lamping DL, McKee CM, Sanderson CF, Askham J, et al. Consensus development methods, and their use in clinical guideline development. Health Technol Assess 1998;2:i-iv, 1-88. (Pubitemid 28166175)
23. Hagemans ML, Winkel LP, Hop WC, Reuser AJ, Van Doorn PA, Van der Ploeg AT. Disease severity in children and adults with Pompe disease related to age and disease duration. Neurology 2005;64:2139-2141. (Pubitemid 40881011)
24. Kroos MA, Pomponio RJ, Hagemans ML, Keulemans JL, Phipps M, DeRiso M, et al. Broad spectrum of Pompe disease in patients with the same c.-32-13T->G haplotype. Neurology 2007;68:110-115. (Pubitemid 46071893)
25. Engel AG, Hirschhorn R, Huie M. Acid maltase deficiency. In: Engel AG, Franzini-Armstrong C, editors. Myology, 3rd ed. New York: McGraw-Hill; 2004:1559-1586.
26. Kretzschmar HA, Wagner H, Hübner G, Danek A, Witt TN, Mehraein P. Aneurysms and vacuolar degeneration of cerebral arteries in late-onset acid maltase deficiency. J Neurol Sci 1990;98:169-183. (Pubitemid 20288812)
27. Refai D, Lev R, Cross DT, Shimony JS, Leonard JR. Thrombotic complications of a basilar artery aneurysm in a young adult with Pompe disease. Surg Neurol 2008;70:518-520.
28. Barohn RJ, McVey AL, DiMauro S. Adult acid maltase deficiency. Muscle Nerve 1993;16:672-676.
29. Amato AA. Acid maltase deficiency and related myopathies. Neurol Clin 2000;18:151-165. (Pubitemid 30117179)
30. Groen WB, Leen WG, Vos AM, Cruysberg JR, van Doorn PA, van Engelen BG. Ptosis as a feature of late-onset glycogenosis type II. Neurology 2006;67:2261-2262. (Pubitemid 46035495)
31. Fernandez C, de Paula AM, Figarella-Branger D, Krahn M, Giorgi R, Chabrol B, et al. Diagnostic evaluation of clinically normal subjects with chronic hyperCKemia. Neurology 2006;66:1585-1587. (Pubitemid 43958564)
32. Hagemans ML, van Schie SP, Janssens AC, van Doorn PA, Reuser AJ, van der Ploeg AT. Fatigue: an important feature of late-onset Pompe disease. J Neurol 2007;254:941-945. (Pubitemid 47222300)
33. Mellies U, Stehling F, Dohna-Schwake C, Ragette R, Teschler H, Voit T. Respiratory failure in Pompe disease: treatment with noninvasive ventilation. Neurology 2005;64:1465-1467. (Pubitemid 40570526)
34. Puruckherr M, Pooyan P, Girish MR, Byrd RP Jr, Roy TM. Successful treatment of respiratory insufficiency due to adult acid maltase deficiency with noninvasive positive pressure ventilation. Sleep Med 2004;5:379-381. (Pubitemid 38842736)
35. Felice KJ, Alessi AG, Grunnet ML. Clinical variability in adult-onset acid maltase deficiency: report of affected sibs and review of the literature. Medicine (Baltimore) 1995;74:131-135.
36. Margolis ML, Howlett P, Goldberg R, Eftychiadis A, Levine S. Obstructive sleep apnea syndrome in acid maltase defi- ciency. Chest 1994;105:947-949. (Pubitemid 24088493)
37. Mellies U, Ragette R, Schwake C, Baethmann M, Voit T, Teschler H. Sleep-disordered breathing and respiratory failure in acid maltase deficiency. Neurology 2001;57:1290-1295. (Pubitemid 32947390)
38. Moufarrej NA, Bertorini TE. Respiratory insufficiency in adult-type acid maltase deficiency. South Med J 1993;86:560-567. (Pubitemid 23150700)
39. Dhand UK, Dhand R. Sleep disorders in neuromuscular diseases. Curr Opin Pulm Med 2006;12:402-408.
40. Soliman OI, van der Beek NA, van Doorn PA, Vletter WB, Nemes A, Van Dalen BM, et al. Cardiac involvement in adults with Pompe disease. J Intern Med 2008;264:333-339.
41. Pellegrini N, Laforet P, Orlikowski D, Pellegrini M, Caillaud C, Eymard B, et al. Respiratory insufficiency and limb muscle weakness in adults with Pompe's disease. Eur Respir J 2005;26:1024-1031. (Pubitemid 41829932)
42. Di Fiore MT, Manfredi R, Marri L, Zucchini A, Azzaroli L, Manfredi G. Elevation of transaminases as an early sign of late-onset glycogenosis type II. Eur J Pediatr 1993;152:784. (Pubitemid 23257929)
43. Hoeksma M, Boon M, Niezen-Koning KE, van Overbeek-van Gils L, van Spronsen FJ. Isolated elevated serum transaminases leading to the diagnosis of asymptomatic Pompe disease. Eur J Pediatr 2007;166:871-874. (Pubitemid 46988166)
44. Daube JR, Rubin DI. Electrodiagnosis of muscle disorders. In: Engel AG, Franzini-Armstrong C, editors. Myology, 3rd ed. New York: McGraw-Hill; 2004:641.
45. de Jager AEJ, van der Vliet TM, van der Ree TC, Oosterink BJ, Loonen MC. Muscle computed tomography in adult-onset acid maltase deficiency. Muscle Nerve 1998;21:398-400. (Pubitemid 28096051)
46. Pichiecchio A, Uggetti C, Ravaglia S, Egitto MG, Rossi M, Sandrini G, et al. Muscle MRI in adult-onset acid maltase deficiency. Neuromuscul Disord 2004;14:51-55. (Pubitemid 37498223)
47. van der Ploeg AT. Monitoring of pulmonary function in Pompe disease: a muscle disease with new therapeutic perspectives. Eur Respir J 2005;26:984-985. (Pubitemid 41829925)
48. Ward NS, Hill NS. Pulmonary function testing in neuromuscular disease. Clin Chest Med 2001;22:769-781. (Pubitemid 34020013)
49. Syabbalo N. Assessment of respiratory muscle function and strength. Postgrad Med J 1998;74:208-215. (Pubitemid 28187878)
50. An Y, Young SP, Hillman SL, Van Hove JL, Chen YT, Millington DS. Liquid chromatographic assay for a glucose tetrasaccharide, a putative biomarker for the diagnosis of Pompe disease. Anal Biochem 2000;287:136-143.
51. Rozaklis T, Ramsay SL, Whitfield PD, Ranieri E, Hopwood JJ, Meikle PJ. Determination of oligosaccharides in Pompe disease by electrospray ionization tandem mass spectrometry. Clin Chem 2002;48:131-139. (Pubitemid 34038132)
52. Wierzba-Bobrowicz T, Lewandowska E, Lugowska A, Rola R, Stepien T, Ryglewicz D, et al. Adult glycogenosis type II (Pompe's disease): morphological abnormalities in muscle and skin biopsies compared with acid alpha-glucosidase activity. Folia Neuropathol 2007;45:179-186. (Pubitemid 351149043)
53. Nascimbeni AC, Fanin M, Tasca E, Angelini C. Molecular pathology and enzyme processing in various phenotypes of acid maltase deficiency. Neurology 2008;70:617-626. (Pubitemid 351294639)
54. Schoser BGH, Müller-Höcker J, Horvath R, Gempel K, Pongratz D, Lochmüller H, et al. Adult-onset glycogen storage disease type 2: clinico-pathological phenotype revisited. Neuropathol Appl Neurobiol 2007;33:544-559. (Pubitemid 47390078)
55. Kallwass H, Carr C, Gerrein J, Titlow M, Pomponio R, Bali D, et al. Rapid diagnosis of late-onset Pompe disease by fluorometric assay of α-glucosidase activities in dried blood spots. Mol Genet Metab 2007;90:449-452. (Pubitemid 46484430)
56. Zhang H, Kallwass H, Young SP, Carr C, Dai J, Kishnani PS, et al. Comparison of maltose and acarbose as inhibitors of maltase-glucoamylase activity in assaying acid alpha-glucosidase activity in dried blood spots for the diagnosis of infantile Pompe disease. Genet Med 2006;8:302-306. (Pubitemid 44297317)
57. University of Washington, Seattle. GeneTests. http://www.genetests.org. Accessed February 26, 2008.
58. Jack RM, Gordon C, Scott CR, Kishnani PS, Bali D. The use of acarbose inhibition in the measurement of acid alphaglucosidase activity in blood lymphocytes for the diagnosis of Pompe disease. Genet Med 2006;8:307-312. (Pubitemid 44297318)
59. Okumiya T, Keulemans JL, Kroos MA, Van der Beek NM, Boer MA, Takeuchi H, et al. A new diagnostic assay for glycogen storage disease type II in mixed leukocytes. Mol Genet Metab 2006;88:22-28.
60. Pompe Center. Mutations in human acid alpha-glucosidase. Volume 2008.
61. Montalvo AL, Bembi B, Donnarumma M, Filocamo M, Parenti G, Rossi M, et al. Mutation profile of the GAA gene in 40 Italian patients with late onset glycogen storage disease type II. Hum Mutat 2006;27:999-1006. (Pubitemid 44454052)
62. Pompe Center ErasmusMC Rotterdam Website. http://www.pompecenter.nl/en/? Molecular-aspects:DNA. Updated May 22, 2007. Accessed July 16, 2008.